Divert, Inc. is a Concord, Massachusetts impact technology company on a mission to prevent food from being wasted. Founded in 2007, it pairs data-driven prevention software with reverse logistics and a network of anaerobic digestion facilities that turn unsold and non-donatable food into renewable natural gas and soil amendment. Divert serves more than 7,800 retail and industrial customer locations - including Kroger, Albertsons, Target, CVS and Ahold Delhaize - and reached a valuation of over $1 billion following a 2026 Series C led by Mitsubishi Corporation.
EatWell is a Boston-based social-impact startup that turns meal kits into a healthcare intervention. Founded by Harvard School of Public Health students, it produces prescription meal kits - fresh ingredients plus fast, culturally relevant recipes designed by a Michelin-trained chef - that healthcare providers and insurers prescribe to patients facing food insecurity and chronic disease. Kits are made in Dorchester at CommonWealth Kitchen by production staff hired from the communities EatWell serves, and are reimbursed through MassHealth ACO Flexible Services and health-system partnerships under the growing 'Food is Medicine' model.
Replate is a tech-enabled nonprofit that reduces food waste and food insecurity by connecting businesses with surplus food to nearby community organizations. Through a web-based platform, companies schedule on-demand or recurring pickups in a few clicks, and Replate's 'Friendly Food Rescuers' collect and deliver the food along optimized routes. Donors track the social and environmental impact of every donation - meals delivered, water saved, and CO2 diverted - through a personalized dashboard. Founded in 2016 by Maen Mahfoud, Replate operates across major U.S. cities and the Middle East.
Foodsmart (formerly Zipongo) is a San Francisco-based telenutrition company that pairs registered dietitians with a food benefits marketplace to treat diet-related chronic disease and food insecurity. It serves more than 2.2 million members across employer plans, Medicaid managed care, Medicare Advantage and commercial insurers, and in 2024 raised $200M led by TPG's The Rise Fund to expand its 'Foodscripts' food-as-medicine programs with major U.S. health systems.